• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Evidence-Based Oncology: Future of Incentive-Driven Pathway Adherence

Video

Evidence-Based Oncology: Future of Incentive-Driven Pathway Adherence, developed in collaboration with Healthcare Research & Analytics (HRA), outlines what the real impact of clinical pathways are on the oncology practice and what the key drivers of clinical pathways use are for both payers and providers.

The American Journal of Managed Care

Evidence-Based Oncology: Future of Incentive-Driven Pathway Adherence, developed in collaboration with Healthcare Research & Analytics (HRA), outlines what the real impact of clinical pathways are on the oncology practice and what the key drivers of clinical pathways use are for both payers and providers. Hosted by Drew Colon, Associate Publisher of , and Kevin Kelly, Executive VP and General Manager of HRA, this 30 minute webinar looks at the changing paradigm of the definition of value in oncology through implementation of and adherence to incentive-driven clinical pathways.

Related Videos
Leslie Fish, PharmD.
Ronesh Sinha, MD
Adam Colborn, JD
Beau Raymond, MD
Judith Alberto, MHA, RPh, BCOP, director of clinical initiatives, Community Oncology Alliance
Yuqian Liu, PharmD
Jenny Craven, PharmaD, BCPS
Kimberly Westrich, MA
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Sarah Bajorek, PhD, BCACP, MBA.
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.